Mipholate-S

Mipholate-S Tablet is an immunosuppressant. Mipholate-S Tablet has been prescribed to you to help your body accept the donor kidney. It does so by working on the cells of your immune system, which fight with any foreign substance and reject its presence. This helps in making the transplanted organ more acceptable to your body.

Mipholate-S Tablet may increase your chances of certain cancers like skin cancer and lymphoma (cancer of the lymph system). When outside, avoid unnecessary or prolonged exposure to sunlight, wear protective clothing, and apply sunscreen. Call your doctor if you experience a new skin sore or bump, a change in the size or color of a mole, a brown or black skin lesion (sore) with uneven edges, a sore whose one part does not look like the other, skin changes, sores that do not heal, unexplained fever, tiredness that does not go away, weight loss, or pain or swelling in the neck, groin, or armpits.

Mipholate-S Tablet is neither a steroid nor a chemotherapy medicine. It is an immunosuppressant which means that it acts on your immune system to suppress or weaken it so that your body does not reject the donated organ of another person. Hair loss is a common side effect of Mipholate-S Tablet.

Since Mipholate-S Tablet can affect blood count and affect the kidneys and liver, your doctor will ask you to have a blood test before you start the treatment. Once the treatment starts, you will be required to take regular blood tests to check for any changes in the blood. These blood tests will help monitor your response to the medicine and the development of any side effects.

Mipholate-S Tablet is an immunosuppressant, which means that it decreases the activity of the immune system. Since your immune system is already weak, if you come in contact with a patient of chicken pox or shingles, you may develop it too. This is the reason that your doctor has advised you to be cautious. Therefore, follow your doctor’s advice and contact your doctor immediately if you get chicken pox or shingles as you may require special treatment.

Do not take Mipholate-S Tablet if you are pregnant or are planning a pregnancy. There is a high risk of miscarriage (loss of the pregnancy) during the first 3 months of pregnancy. It may even cause birth defects (problems that are present at birth) in the baby. Therefore, you must use two acceptable forms of birth control together for 4 weeks before you start taking Mipholate-S Tablet, during the treatment, and for 6 weeks after you stop taking Mipholate-S Tablet. Your doctor will suggest the two birth control methods which suit you the best. It is important to use a second form of birth control along with birth control pills as Mipholate-S Tablet may decrease the effectiveness of birth control pills.

It is recommended that either the man or her partner should use reliable contraception during treatment and for 90 days after the treatment. Men should not donate semen during the therapy or for 90 days following discontinuation of Mipholate-S Tablet.